Latest Conference Articles
Understanding Long-Term Pediatric SARS-CoV-2 Antibodies
October 2nd 2021, 1:00pm
A new study from IDWeek showed most observed children previously infected with SARS-CoV-2 retained antibodies over 6 months.
Increased Hygiene, Motivated by COVID-19, Led to Fewer C Difficile Cases
October 1st 2021, 8:17pm
The COVID-19 pandemic led people to take hygiene and sanitation more seriously, causing a decrease in C difficile infections.
Ferring's Investigational Therapy RBX2660 Demonstrates Another Potential Offering for C Diff Treatment
October 1st 2021, 7:24pm
A clinician provides an overview of the data on the microbiota-based live biotherapeutic, RBX2660, which in phase 3 studies has shown safety and reduction in recurrent C difficile infection (rCDI).
Risk Factors Associated with Readmission after COVID-19 Hospitalization
October 1st 2021, 6:34pm
After an initial hospitalization for COVID-19, some patients may have specific risk factors that increase their likelihood of readmittance.
Antimicrobial Resistance and Changes to the Gut Microbiome after International Travel
October 1st 2021, 5:01pm
Massachusetts General Hospital investigated how international travel contributes to the contraction and carriage of antimicrobial resistance (AMR).
People Living With HIV Experience a Diminished Immune Response to COVID-19 mRNA Vaccines
October 1st 2021, 3:15pm
Major predictors of response were CD4+ count, suppressed viral load, and whether the participant received the Moderna or Pfizer mRNA vaccine.
Delta Variant Causes Unprecedented COVID-19 Disease in Children
October 1st 2021, 3:00pm
The Arkansas Health Department’s research showed that, as with the rest of the population, Delta is severely infectious for children.
Assessing Breakthrough Infections Associated with the AZD1222 Vaccine
October 1st 2021, 2:00pm
Investigators examined asymptomatic infection and the duration of viral shedding in symptomatic breakthrough infections in a phase 3 study with the AZD1222 COVID-19 vaccine.